Clinical Study
Helicobacter pylori Infection and Light Chain Gammopathy
Table 3
Treatment regimen for H. Pylori patients.
| Regimen | Count |
| Clarithromycin 500 mg po bid, metronidazole 500 mg po tid, omeprazole 20 mg po qid, and bismuth subsalicylate 1 tbsp tid | 15 | Tetracycline 500 mg po qid, metronidazole 250 mg po tid, omeprazole 20 mg po bid, and bismuth subsalicylate 1 tbsp tid | 2 | Tetracycline 500 mg po qid, amoxicillin 500 mg po tid, omeprazole 20 mg po bid, and bismuth subsalicylate 1 tbsp tid | 1 | Tetracycline 500 mg po qid, clarithromycin 500 mg po bid, omeprazole 20 mg po bid, and bismuth subsalicylate 1 tbsp tid | 1 | Clarithromycin 500 mg po bid, metronidazole 500 mg po tid, lansoprazole 20 mg po bid, and bismuth subsalicylate 1 tbsp tid | 1 | Clarithromycin 500 mg po bid, amoxicillin 500 mg po tid, lansoprazole 20 mg po bid, and bismuth subsalicylate 1 tbsp tid | 1 |
|
|
All regimens initially lasted between 7 and 10 days. Two of the patients were retreated multiple times.
|